News CBD European Novel Food Regulations; The Why, When And Wherefore

European Novel Food Regulations; The Why, When And Wherefore

-

Advertising

MAKERS and sellers of CBD (cannabidiol) products should conform to the European Union Novel Food regulations introduced in January 2019.

Under European Union law, food that has not been consumed to a significant degree by humans in the EU before May 15, 1997 – when the first Novel Food classification was introduced – is considered a Novel Food. 

There are three routes by which a Novel Food can be approved:

-By showing significant history of use in the EU prior to 1997

-A full application based on submission of a dossier for a Novel Food authorisation.

-Demonstrating the food is a ‘traditional’ one from a third country, where a history of safe food use for at least 25 years can be demonstrated. Examples here include; haskap berries and fonio seeds, traditionally eaten in Japan and West Africa, respectively.

CBD Is ‘Not’ A Novel Food

Wholesale enforcement of the CBD Novel Food rules has barely started, while authorities in the 27 member EU states consider how best to proceed.

But, the Novel Food ruling has opened a wide chasm in the industry.

On one-side are those who say hemp, cannabis and CBD extracts have an established history of use, and on the other, those who contend adhering to the Novel Food benchmark will allow for the creation of well-regulated and compliant CBD market-place.

Three trade groups namely; The Cannabis Trades Association, The European Industrial hemp Association and CannaPro say CBD is not novel.

Some are challenging its designation using an Article 4 route which permits an opportunity to demonstrate the food in question has been used prior to May 1997.

A second challenge is being considered under an Article 5 route which says the ‘EC may decide, on its own initiative or upon a request by a Member State…whether or not a particular food falls within the definition of Novel Food’.

Novel Food Pathway

In the UK the Food Standards Agency (FSA) says it expects all companies wanting to sell CBD products after March 31, 2020, to have an application for a Novel Food authorisation validated by either itself or the European Union.

The FSA has chosen to maintain this alignment with the Novel Food standard as the UK leaves the European Union in January 2021.

Czech Republic firm Cannabis Pharma was one of the first to submit a Novel Food application and it was recently been reported that dozens more have been submitted to the European Union.

Once lodged it could take a further two years for an application to be approved, say industry experts.

Completing a submission to regulators to secure a Novel Food authorisation is also expensive business – with some saying it will cost at least £200,000.

ACI Supports A Well-Regulated Industry

The UK-based Association of the Cannabinoid Industry (ACI) believes the rigorous standards required for a Novel Food authorisation will boost public confidence in the existence of a safe CBD industry.

A Novel Food authorisation will ensure the CBD product in question is safe and stable and capable of being produced in the same manner – batch after batch, after batch.

This could prove to be a significant challenge as whole plant extracts can contain over 100 cannabinoids and ensuring that such a complex combination of compounds are replicated over time could prove an Herculean – and expensive – challenge.

As a result, CBD isolates may well come to dominate the market in the years to come. 

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Europe’s Top Judges Praised For Their ‘Courage’ In Delivering Major Boost To CBD Industry

KANAVAPE lawyer Eveline Van Keymeulen has praised five of Europe’s most senior judges for their courage in rejecting the...

Markets: US Firm Swoops For UK Medical Cannabis Company, EMMAC, Alphagreen, Ananda et al…

AMERICAN firm Halo Labs has snapped up UK medicinal cannabis supplier Canmart in a share-based deal. Kent-based Canmart was one...

Walking In The Light With Carlos Santana And Prohibition Partners

MUSIC legend Carlos Santana rounded-off this year’s second Prohibition Partners Live discussing his new cannabis venture, his relationship with...

European Commission Under Increasing Pressure To Scrap Its Classification Of CBD As A Narcotic Drug Following Court Ruling

THE European Court of Justice has handed the continent’s hemp and CBD industry a major boost - now the...

Advertising

Huge Result For CBD Industry With Europe’s Top Court Saying It Is Not A Narcotic

THE KanaVape ruling is in and it's a massive win for the CBD industry with the ECJ saying that...

KanaVape’s Antonin Cohen Speaks To BusinessCann After Winning His Six-Year CBD Court Battle With Europe

A JOYFUL Antonin Cohen has spoken of his delight - and relief - after successfully winning a court battle...

Must read

Europe’s Top Judges Praised For Their ‘Courage’ In Delivering Major Boost To CBD Industry

KANAVAPE lawyer Eveline Van Keymeulen has praised five of...

Markets: US Firm Swoops For UK Medical Cannabis Company, EMMAC, Alphagreen, Ananda et al…

AMERICAN firm Halo Labs has snapped up UK medicinal...

Advertising

You might also likeRELATED
Recommended to you